Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 30, 2017New England Journal of MedicineOpen Access

Liraglutide and Renal Outcomes in Type 2 Diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJohannes F.E. MannPreventive CardiologyDØDavid D. ØrstedNovo Nordisk (Denmark)KBKirstine Brown‐FrandsenNovo Nordisk (Denmark)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mann et al. (2017) studied this question.

synapsesocial.com/papers/69effb1eafa91c76b5d0a758https://doi.org/10.1056/nejmoa1616011
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes2016 · 7,640 citations
  2. 2Effects of Intensive Glucose Lowering in Type 2 Diabetes2008 · 7,952 citations
  3. 3Diabetes and Cause-Specific Mortality in Mexico City2016 · 290 citations
  4. 4Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015 · 12,305 citations
  5. 5Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease2011 · 270 citations